ABarginase, the first-in-class drug for multiple obesity-related metabolic diseases

Researchers from The Hong Kong Polytechnic University (PolyU) and The Chinese University of Hong Kong (CUHK) have jointly made a groundbreaking drug discovery in treating multiple metabolic diseases related to obesity and insulin resistance like diabetes and fatty liver disease…
Read More